Loading market dashboard
CVS Health Corporation
CVSHealthcareNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
The latest trading day saw CVS Health (CVS) settling at $95.93, representing a +1.17% change from its previous close.
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?
Morgan Stanley names UnitedHealth its top managed care pick, citing AI-driven growth, efficiency gains and improving operations.
It's another step in Eli Lilly's quest to cement its lead in the chronic weight management market.
Health insurers are running higher in Thursday afternoon trading after a wave of bullish Wall Street analyst notes on the managed-care sector, centered on UnitedHealth, citing softer medical cost and utilization trends plus potential AI efficiency upside.
CVS Health (CVS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
After its blockbuster Q1 2026 earnings report that caused shares to gain 9.8%, pharmaceutical behemoth Eli Lilly and Company NYSE: LLY continues to rack up wins. These include a Food and Drug Administration (FDA) proposal that would pressure compounders, as well as strong clinical results for its oral GLP-1, Foundayo.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
AbbVie, CVS Health, and Verizon Communications are all high-yielding stocks with attractive valuations and robust financials.
These aren't the most exciting businesses, but they have a lot to offer to long-term investors.
CVS Health may beat UnitedHealth Group in terms of forward dividend yield, but when it comes to dividend growth, it's no contest. UnitedHealth Group has raised its dividend during each of the past 16 years, while CVS hasn't raised its payout in over two years.
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The company was awarded a 2026 Newsweek AI Impact Award WOONSOCKET, R.I., May 29, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced it has been recognized by Newsweek with the 2026 AI Impact Award in the AI Health Care category, specifically for Best Outcomes – Patient Care.
In the initial launch, Aetna clinicians connected with members in just 13 seconds HARTFORD, Conn., May 28, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS) today announced Aetna Mental Health On Demand to broaden access to care and give members greater control over their mental health journey.
CVS Health hasn't cut its dividend, but it has paused annual increases on occasion. CVS's cash flow is more than enough to cover its dividend obligations.
That means millions more Americans may get access to Lilly's new GLP-1 pill Foundayo or the GLP-1 injection Zepbound.
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- H1 recently received a $40M investment in a round led by CVS Health Ventures , the venture capital investment platform of CVS Health dedicated to driving health care innovation and digital disruption. The investment follows several successful projects that CVS Health and H1 have collaborated on, including a new AI model leading to a substantial improvement in health care provider directory accuracy, helping people connect with health care providers more quickly.
BOSTON--(BUSINESS WIRE)--athenahealth today announced it received 2026 KLAS Points of Light and K2 Collaborative Peak awards alongside Aetna CVS Health and Catalyst Health Group for their joint effort to advance real-time clinical data exchange across payer and provider workflows. This initiative demonstrates how interoperable, real-time access to clinical information can reduce administrative friction and support more seamless care coordination between payers and providers. “Value-based care d.
Collaboration will improve call center experience for members and 1.5 million providers with AI agents SAN FRANCISCO and WOONSOCKET, R.I., May 28, 2026 /PRNewswire/ -- Salesforce (NYSE: CRM), the world's #1 AI CRM, and CVS Health (NYSE: CVS), a leading health care solutions company which serves 185 million people each year, today announced an expansion of their collaboration to simplify and streamline call center interactions for members and providers across multiple CVS Health businesses.
CVS Health said on Thursday it will add Eli Lilly's weight-loss drug Zepbound back to some of its drug lists as an additional preferred option for insurance coverage.
CVS Health said it will restore coverage of Eli Lilly's blockbuster weight loss injection Zepbound and start covering its new obesity pill on its standard drug plans. The move supports Lilly's efforts to maintain its dominance over Novo Nordisk in the blockbuster weight loss drug market, as it puts the two drugmakers on equal footing on major drug plans.
Expanded GLP-1 options for members create a path to sustainable coverage of these important medications WOONSOCKET, R.I., May 28, 2026 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced updates to its most common commercial formularies, expanding GLP-1 options for members— including the reintroduction of Zepbound® (tirzepatide) as a covered medication.
HARTFORD, Conn., May 26, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced the launch of the second generation Aetna Claims Assist Manager (CAM), an AI-powered agentic claims advisor platform designed to streamline claims processing and improve payment accuracy.
CVS Group (AIM:CVSG) has launched a £50 million share buyback after refinancing its banking facilities as the veterinary chain stepped up expansion plans in Australia following the end of a lengthy UK competition probe. The FTSE 250-listed group said it had refinanced its £350 million debt facilities on improved terms, extending maturities to May 2030 and lowering borrowing margins by 20 basis points.
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
NEW YORK, May 21, 2026 /PRNewswire/ -- Two years ago, we established a concentrated position in shares of CVS Health (NYSE: CVS). Since our purchases in May 2024, CVS shares have generated a total return of 80%, reflecting progress in the long-term cultural and operational turnaround underway at the Company.
CVS Health's collaboration with Diocesan Housing Services Corporation and The Walters Group supports the new construction of Mews at St. Mary WOONSOCKET, R.I., May 21, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today joined The Diocesan Housing Services Corporation (DHSC) of the Diocese of Camden, The Walters Group, The United States Department of Housing and Urban Development (HUD), the New Jersey Housing and Mortgage Finance Agency (NJHMFA), and community leaders to celebrate the grand opening and building dedication of The Mews at St. Mary, a new 75-unit senior affordable housing property located in Williamstown, New Jersey.
@Theotrade's Don Kaufman breaks down today's Big 3. He includes a bullish call spread on Nike (NKE), a bearish outlook on CVS Health (CVS), and explains why he sees Cisco (CSCO) as a steal at current prices.
Delivering care, connection, and opportunity to military ‑ connected families nationwide WOONSOCKET, R.I., May 20, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) is reaffirming its commitment to supporting service members, veterans, their families and caregivers through a comprehensive approach that spans health care access, community‑based solutions, purpose‑driven engagement and economic opportunity.
CVS is more than a dividend play.
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Looking past stocks because they trade at high trailing earnings multiples can be a costly mistake for investors.
Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Majority of respondents believe that low digital literacy is having a negative impact on their ability to manage their health CVS Health continues to launch innovative digital offerings to help members access care, as part of its $20 billion technology investment, announced in 2025 WOONSOCKET, R.I., May 18, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS), today released "Navigating the Digital Health Literacy Gap," a research-based white paper revealing a significant gap between older Americans' current ability to navigate digital health tools and their interest and openness to learning more.
Our 24/7 Wall St. price target for CVS Health (NYSE:CVS | CVS Price Prediction) is $125.45, pointing to meaningful upside from where shares trade today.
A bankruptcy court has approved the sale of CVS Health's underperforming Omnicare long-term care pharmacy network to GenieRx in a deal valued at $250 million.
New program helps reduce financial barriers to higher education while building a stronger, more robust pharmacy workforce WOONSOCKET, R.I., May 14, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) and WGU today announced a new online pre-pharmacy degree program designed to help address the national need for pharmacists through flexible, affordable education.
Omnicare, a unit of health insurer CVS Health , said on Wednesday a U.S. bankruptcy court has approved the sale of its business to GenieRx Holdings.
WOONSOCKET, R.I., May 13, 2026 /PRNewswire/ -- Omnicare, LLC (the "Company" or "Omnicare"), a subsidiary of CVS Health (NYSE: CVS), today announced that following a comprehensive sale process, the U.S. Bankruptcy Court for the Northern District of Texas (the "Court") has approved the sale of the Company's business to GenieRx Holdings LLC ("GenieRx"), a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Asset Management LLC, which does business as Integro Healthcare Services.
In-person and virtual services support chronic disease prevention and long-term metabolic health WOONSOCKET, R.I., May 13, 2026 /PRNewswire/ -- As chronic conditions tied to metabolic health continue to rise across the United States, MinuteClinic®, the medical clinic inside select CVS Pharmacy® (NYSE: CVS) locations, is highlighting its clinically supervised weight-loss program to support earlier intervention and more accessible preventive care.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The healthcare giant's stock is up after it posted another solid quarter, which showed a big improvement in its bottom line.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CVS Health Corporation remains deeply undervalued despite persistent headwinds and an 11-year correction, with intrinsic value estimates well above current prices. Q1 2026 results showed 6.2% revenue growth and a 63.1% EPS increase, prompting management to raise full-year guidance for revenue, cash flow, and earnings. Margins and the medical benefit ratio are showing early signs of recovery, supporting management's and analysts' renewed optimism for double-digit EPS growth.
CVS Health NYSE: CVS raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with management citing improved performance at Aetna, continued execution at Caremark and resilient pharmacy operations.
The +2.48% YoY payment hike for 2027 Medicare Advantage plans and Aetna's higher star rating support CVS Health's recovery prospects toward 2028 target margins. This is significantly aided by the prior premium re-pricing and the ongoing operational efficiencies, as observed in their FQ1 '26 MBR of 84.6% nearing 2019 levels. Readers must not forget their vertically integrated PBM and pharmacy capabilities, allowing them to drive lower medical costs and improved operational efficiencies.
CVS Health Corp. (NYSE:CVS) on Wednesday posted upbeat first-quarter earnings and issued strong 2026 guidance.
CVS Health Corporation delivered a strong Q1, with revenues of $100.4bn and adjusted EPS up ~14% to $2.57, surpassing expectations. CVS raised 2026 guidance: revenue to $405bn, adjusted EPS to $7.4, and cash flow from operations to $9.5bn, reflecting renewed operational momentum. Improvement in the medical benefit ratio to 84.6% and robust health insurance segment profitability signal a turnaround in CVS's core business.
Its top line exceeded $100 billion. The company also lifted its guidance for annual adjusted net income.
Pre-market futures are up nicely this morning as “Peace in the Middle East” once again grabs headlines. The U.S. has paused its three-day blockade at the Gulf of Oman, allowing for safe passage of commercial ships through the Strait of Hormuz.
CVS Health Corporation (CVS) Q1 2026 Earnings Call Transcript
CVS Health Corp (NYSE:CVS) shares rose about 6% on Wednesday morning after the retail pharmacy chain reported first quarter financial results that topped Wall Street expectations on both earnings and revenue. The company posted adjusted earnings per share (EPS) of $2.57, compared with analyst estimates of $2.21.
CVS beats Q1 estimates as revenues hit $100.43B, margins expand, and 2026 guidance is raised. Shares jump 4.8% in pre-market.
Beyond obvious strength in Healthcare, we're starting to see "green shoots" in industries that a year ago were seeing negative growth.
Stock futures are surging as oil prices plunge amid optimism that the end of the Iran war could be in sight; a report this morning indicates that the U.S. and Iran are close to reaching a deal to end the conflict, after President Trump on Tuesday said "great progress" was being made; AMD shares are soaring after the chipmaker's results topped Wall Street estimates, the latest sign of continued strong demand for AI hardware; Novo Nordisk shares are rising after the maker of Ozempic and Wegovy reported solid quarterly results; and shares of Disney, CVS and Uber are gaining ground after reporting results on a busy day for earnings. Here's what you need to know today.
CVS Health (CVS) came out with quarterly earnings of $2.57 per share, beating the Zacks Consensus Estimate of $2.21 per share. This compares to earnings of $2.25 per share a year ago.
CVS Health Wednesday reported first quarter net income of more than $2.9 billion as costs slowed for subscribers of the Aetna health plans the company sells.
